vs
GORMAN RUPP CO（GRC）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是GORMAN RUPP CO的1.3倍（$219.9M vs $166.6M），GORMAN RUPP CO净利率更高（8.3% vs -1.0%，领先9.3%），GORMAN RUPP CO同比增速更快（2.4% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $10.2M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 2.3%）
戈尔曼-拉普是一家总部位于俄亥俄州曼斯菲尔德的泵类制造商，产品面向市政供水、污水处理、工业、建筑、石油、消防及原始设备制造等多个领域提供配套水泵，公司在纽约证券交易所上市，现任首席执行官为斯科特·金。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
GRC vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.3倍
$166.6M
营收增速更快
GRC
高出0.4%
2.0%
净利率更高
GRC
高出9.3%
-1.0%
自由现金流更多
OFIX
多$6.7M
$10.2M
两年增速更快
OFIX
近两年复合增速
2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $166.6M | $219.9M |
| 净利润 | $13.7M | $-2.2M |
| 毛利率 | 31.4% | 71.1% |
| 营业利润率 | 14.9% | 0.2% |
| 净利率 | 8.3% | -1.0% |
| 营收同比 | 2.4% | 2.0% |
| 净利润同比 | 25.2% | 92.4% |
| 每股收益（稀释后） | $0.53 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GRCOFIX
| Q4 25 | $166.6M | $219.9M | ||
| Q3 25 | $172.8M | $205.6M | ||
| Q2 25 | $179.0M | $203.1M | ||
| Q1 25 | $163.9M | $193.6M | ||
| Q4 24 | $162.7M | $215.7M | ||
| Q3 24 | $168.2M | $196.6M | ||
| Q2 24 | $169.5M | $198.6M | ||
| Q1 24 | $159.3M | $188.6M |
净利润GRCOFIX
| Q4 25 | $13.7M | $-2.2M | ||
| Q3 25 | $11.3M | $-22.8M | ||
| Q2 25 | $15.8M | $-14.1M | ||
| Q1 25 | $12.1M | $-53.1M | ||
| Q4 24 | $11.0M | $-29.1M | ||
| Q3 24 | $12.9M | $-27.4M | ||
| Q2 24 | $8.3M | $-33.4M | ||
| Q1 24 | $7.9M | $-36.0M |
毛利率GRCOFIX
| Q4 25 | 31.4% | 71.1% | ||
| Q3 25 | 29.2% | 72.2% | ||
| Q2 25 | 31.3% | 68.7% | ||
| Q1 25 | 30.7% | 62.8% | ||
| Q4 24 | 30.2% | 69.0% | ||
| Q3 24 | 31.3% | 68.7% | ||
| Q2 24 | 31.9% | 67.8% | ||
| Q1 24 | 30.4% | 67.5% |
营业利润率GRCOFIX
| Q4 25 | 14.9% | 0.2% | ||
| Q3 25 | 12.4% | -8.3% | ||
| Q2 25 | 15.0% | -7.9% | ||
| Q1 25 | 13.5% | -25.2% | ||
| Q4 24 | 13.0% | -5.3% | ||
| Q3 24 | 14.2% | -9.6% | ||
| Q2 24 | 15.4% | -12.5% | ||
| Q1 24 | 12.8% | -15.6% |
净利率GRCOFIX
| Q4 25 | 8.3% | -1.0% | ||
| Q3 25 | 6.6% | -11.1% | ||
| Q2 25 | 8.8% | -6.9% | ||
| Q1 25 | 7.4% | -27.4% | ||
| Q4 24 | 6.7% | -13.5% | ||
| Q3 24 | 7.7% | -13.9% | ||
| Q2 24 | 4.9% | -16.8% | ||
| Q1 24 | 5.0% | -19.1% |
每股收益（稀释后）GRCOFIX
| Q4 25 | $0.53 | $-0.05 | ||
| Q3 25 | $0.43 | $-0.57 | ||
| Q2 25 | $0.60 | $-0.36 | ||
| Q1 25 | $0.46 | $-1.35 | ||
| Q4 24 | $0.42 | $-0.76 | ||
| Q3 24 | $0.49 | $-0.71 | ||
| Q2 24 | $0.32 | $-0.88 | ||
| Q1 24 | $0.30 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $35.1M | $82.0M |
| 总债务越低越好 | $307.5M | — |
| 股东权益账面价值 | $414.7M | $450.0M |
| 总资产 | $860.1M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资GRCOFIX
| Q4 25 | $35.1M | $82.0M | ||
| Q3 25 | $42.9M | $62.9M | ||
| Q2 25 | $27.0M | $65.6M | ||
| Q1 25 | $21.8M | $58.0M | ||
| Q4 24 | $24.2M | $83.2M | ||
| Q3 24 | $39.7M | $30.1M | ||
| Q2 24 | $34.2M | $26.4M | ||
| Q1 24 | $27.8M | $27.0M |
总债务GRCOFIX
| Q4 25 | $307.5M | — | ||
| Q3 25 | $322.3M | $157.2M | ||
| Q2 25 | $337.1M | $157.0M | ||
| Q1 25 | $352.2M | $156.9M | ||
| Q4 24 | $366.6M | $157.0M | ||
| Q3 24 | $381.0M | $118.5M | ||
| Q2 24 | $395.4M | $118.0M | ||
| Q1 24 | $400.7M | $118.2M |
股东权益GRCOFIX
| Q4 25 | $414.7M | $450.0M | ||
| Q3 25 | $405.2M | $442.5M | ||
| Q2 25 | $397.8M | $458.3M | ||
| Q1 25 | $382.1M | $458.3M | ||
| Q4 24 | $373.8M | $503.1M | ||
| Q3 24 | $367.3M | $525.9M | ||
| Q2 24 | $358.6M | $546.0M | ||
| Q1 24 | $353.7M | $570.3M |
总资产GRCOFIX
| Q4 25 | $860.1M | $850.6M | ||
| Q3 25 | $869.9M | $832.6M | ||
| Q2 25 | $861.8M | $837.2M | ||
| Q1 25 | $857.8M | $823.1M | ||
| Q4 24 | $858.5M | $893.3M | ||
| Q3 24 | $883.5M | $867.9M | ||
| Q2 24 | $891.1M | $882.0M | ||
| Q1 24 | $887.4M | $906.0M |
负债/权益比GRCOFIX
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.80× | 0.36× | ||
| Q2 25 | 0.85× | 0.34× | ||
| Q1 25 | 0.92× | 0.34× | ||
| Q4 24 | 0.98× | 0.31× | ||
| Q3 24 | 1.04× | 0.23× | ||
| Q2 24 | 1.10× | 0.22× | ||
| Q1 24 | 1.13× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.0M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $10.2M | $16.8M |
| 自由现金流率自由现金流/营收 | 6.1% | 7.6% |
| 资本支出强度资本支出/营收 | 2.9% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.09× | — |
| 过去12个月自由现金流最近4个季度 | $88.9M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流GRCOFIX
| Q4 25 | $15.0M | $27.7M | ||
| Q3 25 | $42.3M | $12.4M | ||
| Q2 25 | $27.8M | $11.6M | ||
| Q1 25 | $21.1M | $-18.4M | ||
| Q4 24 | $9.3M | $23.7M | ||
| Q3 24 | $27.2M | $11.7M | ||
| Q2 24 | $22.7M | $9.0M | ||
| Q1 24 | $10.7M | $-18.6M |
自由现金流GRCOFIX
| Q4 25 | $10.2M | $16.8M | ||
| Q3 25 | $35.8M | $2.5M | ||
| Q2 25 | $24.8M | $4.5M | ||
| Q1 25 | $18.1M | $-25.1M | ||
| Q4 24 | $5.2M | $15.2M | ||
| Q3 24 | $24.0M | $6.3M | ||
| Q2 24 | $19.4M | $-360.0K | ||
| Q1 24 | $6.8M | $-29.1M |
自由现金流率GRCOFIX
| Q4 25 | 6.1% | 7.6% | ||
| Q3 25 | 20.7% | 1.2% | ||
| Q2 25 | 13.9% | 2.2% | ||
| Q1 25 | 11.0% | -13.0% | ||
| Q4 24 | 3.2% | 7.0% | ||
| Q3 24 | 14.3% | 3.2% | ||
| Q2 24 | 11.5% | -0.2% | ||
| Q1 24 | 4.3% | -15.4% |
资本支出强度GRCOFIX
| Q4 25 | 2.9% | 4.9% | ||
| Q3 25 | 3.8% | 4.8% | ||
| Q2 25 | 1.7% | 3.5% | ||
| Q1 25 | 1.8% | 3.5% | ||
| Q4 24 | 2.5% | 4.0% | ||
| Q3 24 | 1.9% | 2.7% | ||
| Q2 24 | 1.9% | 4.7% | ||
| Q1 24 | 2.5% | 5.6% |
现金转化率GRCOFIX
| Q4 25 | 1.09× | — | ||
| Q3 25 | 3.73× | — | ||
| Q2 25 | 1.76× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | 2.10× | — | ||
| Q2 24 | 2.72× | — | ||
| Q1 24 | 1.36× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GRC
| Industrial | $34.7M | 21% |
| Fire Market | $31.4M | 19% |
| Municipal | $25.3M | 15% |
| Agriculture | $22.5M | 14% |
| Repair Parts | $18.9M | 11% |
| Construction | $17.3M | 10% |
| Original Equipment Manufacturer | $10.8M | 7% |
| Petroleum | $5.6M | 3% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
